November 1 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit reached 110.7 million denars ($1.9 million/1.8 million euro) in the first nine months of 2023, compared to just 38.2 million denars booked for the same period last year.